CARCINOMA, RENAL CELL
Clinical trials for CARCINOMA, RENAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, RENAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, RENAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to control kidney cancer when standard meds fail
Disease control Recruiting nowThis study tests whether adding bicalutamide to sunitinib can safely control advanced kidney cancer that has stopped responding to standard targeted therapy. About 28 adults with this type of cancer will receive the combination and be monitored for side effects and tumor shrinkag…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New hope for advanced kidney cancer: experimental drug trial launches
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, for adults with advanced kidney cancer that has spread. The goal is to see if the drug, given alone or with other cancer treatments, can shrink tumors and is safe. Participants must not have had prior treatment for their advanced canc…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 15, 2026 12:00 UTC
-
New hope for advanced cancers? early trial launches
Disease control Recruiting nowThis study tests a new drug, BMS-986340, alone or with other cancer treatments in people with advanced solid tumors that have not responded to standard therapy. The main goal is to find safe doses and check for side effects. About 949 adults with various cancers like lung, breast…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Hope for VHL patients: Long-Term belzutifan trial tracks survival
Disease control Recruiting nowThis study is for people already taking belzutifan in another trial for advanced solid tumors or von Hippel-Lindau (VHL) disease. Belzutifan blocks a protein that helps tumors grow. The goal is to see how long people live and track any side effects over time. About 450 adults wil…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for kidney cancer: vorolanib under the microscope
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that has spread or cannot be removed by surgery. It is for patients who need a second treatment after the first one stopped working. Researchers will track how long patients live without …
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Mushroom-Derived drug targets kidney cancer in dialysis patients
Disease control Recruiting nowThis early-phase trial tests a drug called orellanine in people with advanced kidney cancer who are also on dialysis. The goal is to see if the drug is safe and can shrink tumors. About 75 participants will receive the treatment, and researchers will monitor side effects and canc…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Oncorena AB • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug combo aims to extend life in advanced kidney cancer
Disease control Recruiting nowThis study tests whether adding zanzalintinib to belzutifan helps people with advanced kidney cancer live longer and keep the cancer from growing. About 758 adults whose cancer worsened after standard treatments will receive either the drug combo or belzutifan alone. The goal is …
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
AI reads CT scans to spot early vs. advanced kidney cancer
Diagnosis Recruiting nowThis study is testing whether a computer program (deep learning) can accurately tell early-stage (T1-T2) from more advanced (T3) kidney cancer using standard CT scans. Researchers will train the AI on 1,000 patients' scans and check its accuracy against the actual stage found aft…
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC